| Mark L Palmeri, MD | |
|
2000 Sutter Place, Davis, CA 95616-6201 | |
| (530) 756-6440 | |
| Not Available |
| Full Name | Mark L Palmeri |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2000 Sutter Place, Davis, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912015462 | NPI | - | NPPES |
| 00C509420 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | C50942 (California) | Primary |
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about the Money Follows The Person program: "Richard Hasselbach and Deborah Kadlec met in a nursing home and dreamed of a life together outside its walls. Their health conditions made living on their own a challenge: Hasselbach, 63, is disabled from a stroke and lost a leg to a blocked artery. Kadlec, 52, has multiple sclerosis. They both use wheelchairs and need help with chores such as bathing, cooking and remembering to take their medicines.
A recent study funded by Centers for Disease Control and Prevention Epicenters Program and published in Infection Control and Hospital Epidemiology ( Deverick H. Anderson , M.D., MPH et al., 2013) supports and expands on previously published studies confirming the effectiveness of an automated UV-C-emitting device to combat the pathogens Clostridium difficile (C. diff.), vancomycin-resistant enterococci (VRE) and Acinetobacter spp. – some of the common culprits of health care-associated infections drawing increased attention for hospitals across the country.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, reports a large new Northwestern Medicine study published in PNAS, the first to show the process begins so early.
The concept sounds like the stuff of science fiction: take a pill, and suddenly new tissues grow to replace damaged ones. Researchers at Case Western Reserve and UT Southwestern Medical Center this week announced that they have taken significant steps toward turning this once-improbable idea into a vivid reality.
› Verified 9 days ago
| Entity Name | Oakdale Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598862054 PECOS PAC ID: 4587567490 Enrollment ID: O20040216000564 |
News Archive
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about the Money Follows The Person program: "Richard Hasselbach and Deborah Kadlec met in a nursing home and dreamed of a life together outside its walls. Their health conditions made living on their own a challenge: Hasselbach, 63, is disabled from a stroke and lost a leg to a blocked artery. Kadlec, 52, has multiple sclerosis. They both use wheelchairs and need help with chores such as bathing, cooking and remembering to take their medicines.
A recent study funded by Centers for Disease Control and Prevention Epicenters Program and published in Infection Control and Hospital Epidemiology ( Deverick H. Anderson , M.D., MPH et al., 2013) supports and expands on previously published studies confirming the effectiveness of an automated UV-C-emitting device to combat the pathogens Clostridium difficile (C. diff.), vancomycin-resistant enterococci (VRE) and Acinetobacter spp. – some of the common culprits of health care-associated infections drawing increased attention for hospitals across the country.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, reports a large new Northwestern Medicine study published in PNAS, the first to show the process begins so early.
The concept sounds like the stuff of science fiction: take a pill, and suddenly new tissues grow to replace damaged ones. Researchers at Case Western Reserve and UT Southwestern Medical Center this week announced that they have taken significant steps toward turning this once-improbable idea into a vivid reality.
› Verified 9 days ago
| Entity Name | Swope Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972500593 PECOS PAC ID: 2264403443 Enrollment ID: O20040802001469 |
News Archive
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about the Money Follows The Person program: "Richard Hasselbach and Deborah Kadlec met in a nursing home and dreamed of a life together outside its walls. Their health conditions made living on their own a challenge: Hasselbach, 63, is disabled from a stroke and lost a leg to a blocked artery. Kadlec, 52, has multiple sclerosis. They both use wheelchairs and need help with chores such as bathing, cooking and remembering to take their medicines.
A recent study funded by Centers for Disease Control and Prevention Epicenters Program and published in Infection Control and Hospital Epidemiology ( Deverick H. Anderson , M.D., MPH et al., 2013) supports and expands on previously published studies confirming the effectiveness of an automated UV-C-emitting device to combat the pathogens Clostridium difficile (C. diff.), vancomycin-resistant enterococci (VRE) and Acinetobacter spp. – some of the common culprits of health care-associated infections drawing increased attention for hospitals across the country.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, reports a large new Northwestern Medicine study published in PNAS, the first to show the process begins so early.
The concept sounds like the stuff of science fiction: take a pill, and suddenly new tissues grow to replace damaged ones. Researchers at Case Western Reserve and UT Southwestern Medical Center this week announced that they have taken significant steps toward turning this once-improbable idea into a vivid reality.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark L Palmeri, MD 2100 Powell St, Ste 900, Emeryville, CA 94608-1844 Ph: (510) 350-2842 | Mark L Palmeri, MD 2000 Sutter Place, Davis, CA 95616-6201 Ph: (530) 756-6440 |
News Archive
Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with USA Today, writes about the Money Follows The Person program: "Richard Hasselbach and Deborah Kadlec met in a nursing home and dreamed of a life together outside its walls. Their health conditions made living on their own a challenge: Hasselbach, 63, is disabled from a stroke and lost a leg to a blocked artery. Kadlec, 52, has multiple sclerosis. They both use wheelchairs and need help with chores such as bathing, cooking and remembering to take their medicines.
A recent study funded by Centers for Disease Control and Prevention Epicenters Program and published in Infection Control and Hospital Epidemiology ( Deverick H. Anderson , M.D., MPH et al., 2013) supports and expands on previously published studies confirming the effectiveness of an automated UV-C-emitting device to combat the pathogens Clostridium difficile (C. diff.), vancomycin-resistant enterococci (VRE) and Acinetobacter spp. – some of the common culprits of health care-associated infections drawing increased attention for hospitals across the country.
Hypertension that leads to vascular dementia in older adults begins to impact the brain by middle age, reports a large new Northwestern Medicine study published in PNAS, the first to show the process begins so early.
The concept sounds like the stuff of science fiction: take a pill, and suddenly new tissues grow to replace damaged ones. Researchers at Case Western Reserve and UT Southwestern Medical Center this week announced that they have taken significant steps toward turning this once-improbable idea into a vivid reality.
› Verified 9 days ago
Abram Levin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Sutter Pl, Davis, CA 95616 Phone: 530-757-5111 | |
Ryan N. Gorton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-756-6440 | |
Michael Palchak, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 25133 County Road 96, Davis, CA 95616 Phone: 530-979-7775 Fax: 530-758-6904 | |
Kurt S. Kusserow, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-756-6440 | |
David T. Walters, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-756-6440 | |
Deven Babubhai Merchant, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Sutter Place, Davis, CA 95616 Phone: 530-757-5111 | |
Thomas Jeffrey Ferguson, M.D., PH.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Shields Ave, Davis, CA 95616 Phone: 530-752-2300 Fax: 530-752-2306 |